Advance Agrolife Ltd
NSE: ADVANCE BSE: 544562
Advance Agrolife is engaged in the business of manufacturing and distributor of broad spectrum of technical and formulated grade of agrochemicals.(Source : 202503 Annual Report Page No:33)
₹100
52W: ₹84.1 — ₹154
PE 18.2 · Book ₹48.2 · +107% vs bookMarket Cap₹643 Cr
Stock P/E18.2Price to Earnings
ROCE19.3%Return on Capital
ROE17.2%Return on Equity
Div. Yield0%Face Value ₹10
Strengths
- +Company has delivered good profit growth of 31.3% CAGR over last 5 years
- +Company has a good return on equity (ROE) track record: 3 Years ROE 24.0%
Weaknesses
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Working capital days have increased from 42.3 days to 70.7 days
Shareholding Pattern
Promoters69.89%
FIIs2.58%
DIIs1.92%
Public25.61%
| Category | Dec 2025 | Mar 2026 |
|---|---|---|
| Promoters | 69.89% | 69.89% |
| FIIs | 4.42% | 2.58%▼1.8 |
| DIIs | 2.03% | 1.92%▼0.1 |
| Public | 23.04% | 25.61%▲2.6 |
Financial Statements
| Metric | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 131.84 | 167.42 | 113.17 | 89.83 | 168.63 | 212.63 | 132.64 | 123.88 |
| Expenses | 119.38 | 144.47 | 106.84 | 83.95 | 151.51 | 186.85 | 125.29 | 110.5 |
| Operating Profit | 12.46 | 22.95 | 6.33 | 5.88 | 17.12 | 25.78 | 7.35 | 13.38 |
| OPM % | 9.45% | 13.71% | 5.59% | 6.55% | 10.15% | 12.12% | 5.54% | 10.8% |
| Net Profit | 7.22 | 14.22 | 2.78 | 1.43 | 8.94 | 15.88 | 3.01 | 7.46 |
| EPS ₹ | 16.04 | 31.6 | 6.18 | 0.32 | 1.99 | 3.53 | 0.47 | 1.16 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹638Cr, up 28.6% YoY. OPM at 10%.
Debt Position
Borrowings at ₹98Cr. Debt-to-equity ratio: 0.40x. Healthy balance sheet.
Capex Cycle
CWIP at ₹22Cr (27% of fixed assets). Significant capex underway — growth runway building.
Margin & Efficiency
ROCE improving from 0% (Mar 2021) to 19% (Mar 2026). Working capital days: 71.
Valuation
PE 18.2x with 19.3% ROCE. Price is 107% above book value of ₹48.2. Dividend yield: 0%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 9 May - Newspaper Publication for the Audited Financial Results for the Quarter and Year ended March 31, 2026
- Announcement under Regulation 30 (LODR)-Investor Presentation 8 May - Investors Presentation for the quarter and Financial year ended March 31, 2026
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report 8 May - CARE report for quarter ended March 31, 2026 shows IPO proceeds utilization of Rs. 192.84 crore, with nil deviation.
- Re-Appointment Of Internal & Cost Auditors 8 May - Board approved audited standalone FY26 results on May 8, 2026, with unmodified opinion and auditor reappointments.
- Statement Of Deviation (S) Or Variation (S) For The Quarter Ended March 31, 2026 8 May - No deviation in utilization of ₹1,928.42 million IPO proceeds for quarter ended March 31, 2026.
- Rating update 25 Mar from care
- Rating update 3 Apr 2025 from care
- PPT